Slovak Academy of Sciences   Report issue

Government Phase 2 Phase 3
Founded: Bratislava Slovakia (1942)

Organization Overview

First Clinical Trial
2008
NCT01444833
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Biomedical Research Center Slovak Academy of Sciences | Biomedical Research Center, Slovak Academy of Sciences, | Jozef Ukropec | Slovak Academy of Sciences | The Slovak Academy of Sciences

Active Ingredients

Drugs in Phase 3 Trials (2)

vitamin e (1 trial)

water (1 trial)

Drugs in Phase 2 Trials (5)

bifidobacterium animalis (1 trial)

inulin (1 trial)

lactobacillus rhamnosus (1 trial)

oligofructose (1 trial)

uralenic acid (1 trial)

Drugs in Other Trials (2)

candesartan (atacand) (1 trial)

l-carnosine (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Febrile Neutropenia (Phase 2)

Fever (Phase 2)

Neutropenia (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 9